Skip to main content

Published locations for 'Revolutionary' LDL lowering shown in evolocumab phase III trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. 'Revolutionary' LDL lowering shown in evolocumab phase III trials

User login

  • Reset your password
  • /content/revolutionary-ldl-lowering-shown-evolocumab-phase-iii-trials
  • /familypracticenews/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown
  • /ehospitalistnews/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab
  • /internalmedicinenews/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown
  • /clinicalendocrinologynews/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown
  • /ecardiologynews/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab
  • /cardiology/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab-phase
  • /endocrinology/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab
  • /internalmedicine/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab
  • /familymedicine/article/81320/acute-coronary-syndromes/revolutionary-ldl-lowering-shown-evolocumab